386 related articles for article (PubMed ID: 19562722)
1. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
Audet M; Panaro F; Piardi T; Wolf P
Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
[No Abstract] [Full Text] [Related]
2. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
3. Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation.
Pompili M; Pacella CM; Francica G; Angelico M; Tisone G; Craboledda P; Nicolardi E; Rapaccini GL; Gasbarrini G
Eur J Radiol; 2010 Jun; 74(3):e6-e11. PubMed ID: 19345541
[TBL] [Abstract][Full Text] [Related]
4. Is tumor biopsy necessary?
Müllhaupt B; Durand F; Roskams T; Dutkowski P; Heim M
Liver Transpl; 2011 Oct; 17 Suppl 2():S14-25. PubMed ID: 21744470
[No Abstract] [Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?
Schwartz ME
Hepatology; 1996 Dec; 24(6):1539-41. PubMed ID: 8938193
[No Abstract] [Full Text] [Related]
6. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
[TBL] [Abstract][Full Text] [Related]
7. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
Stock PG; Fung J
Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
[No Abstract] [Full Text] [Related]
8. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular cancer with a background of liver cirrhosis].
Zhuravlev VA; Agalakov VI
Klin Med (Mosk); 1996; 74(2):2-5. PubMed ID: 8772088
[No Abstract] [Full Text] [Related]
10. Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?
Tan KC
Singapore Med J; 2003 Jun; 44(6):309-11. PubMed ID: 14560865
[No Abstract] [Full Text] [Related]
11. Liberal selection criteria for liver transplantation for hepatocellular carcinoma.
Muscari F; Foppa B; Kamar N; Peron JM; Selves J; Suc B
Br J Surg; 2009 Jul; 96(7):785-91. PubMed ID: 19526621
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for early-detected, multifocal hepatocellular carcinoma.
Salizzoni M; Zamboni F; Lupo F; Franchello A; David E; Rizzetto M
Br J Surg; 2001 Sep; 88(9):1194-5. PubMed ID: 11531866
[No Abstract] [Full Text] [Related]
13. [Preoperative evaluation and postoperative complications with prognostic impact of surgical resection for the hepatocellular carcinoma in cirrhotics].
Kang KJ
Korean J Hepatol; 2006 Dec; 12(4):479-83. PubMed ID: 17237625
[No Abstract] [Full Text] [Related]
14. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
[No Abstract] [Full Text] [Related]
15. Usefulness of the Kyoto criteria as selection criteria for living donor liver transplantation for hepatocellular carcinoma.
Kaido T; Takada Y; Uemoto S
Liver Transpl; 2010 Apr; 16(4):538-40. PubMed ID: 20373466
[No Abstract] [Full Text] [Related]
16. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
[No Abstract] [Full Text] [Related]
17. [Liver transplantation for hepatocellular carcinoma].
Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
[No Abstract] [Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma: the Hangzhou experience.
Busuttil RW
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):235-6. PubMed ID: 18522877
[No Abstract] [Full Text] [Related]
19. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
Olthoff KM; Forner A; Hübscher S; Fung J
Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
[No Abstract] [Full Text] [Related]
20. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
